Decreased levels of S-adenosylmethionine (SAM) and hypomethylation of the H-ras gene in transformed pancreatic acinar cells from ddI-treated rats (Meeting abstract). NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Decreased levels of S-adenosylmethionine (SAM) and hypomethylation of the H-ras gene in transformed pancreatic acinar cells from ddI-treated rats (Meeting abstract).

Proc Annu Meet Am Assoc Cancer Res; 38:A1198 1997. Unique Identifier : AIDSLINE ICDB/98638198
Lyn-Cook BD; Wise C; Green B; Johnson J; Jin B; Sandberg JA; Patterson TA; Slikker W; Divisions of Molecular Epidemiology and Neurotoxicology,; FDA/NCTR, Jefferson, Arkansas 72079


Abstract: Acute pancreatitis is often detected in AIDS patients given dideoxyinosine (ddI, Videx), a nucleoside analog. This study was undertaken to determine the molecular effects on normal pancreatic acinar cells in vivo and in vitro from controls and ddI-treated animals. Animals were dosed twice daily with 415 mg/kg ddI for 5, 10, 15, or 20 weeks. Animals dosed more than 10 wks showed decreased levels of SAM using HPLC analysis. Levels in pancreatic tissue after 10 wks were 6.41+/-0.55 for controls and 4.11+/-0.20 for ddI-treated animals. Pancreatic acinar cells isolated from controls and ddI-treated animals and subcultured for several passages revealed a remarkably decreased SAM level (ng of SAM/million cells, controls 34.94+/-5.9 and ddI, 14.02+/-2.34, p less than 0.001). S-adenosylmethionine: S-adenosylhomocysteine (SAM/SAH) ratios were 17.76+/-2.64 for control and 2.96+/-0.07 for ddI (p less than 0.0001). Cultured pancreatic acinar cells from ddI-treated rats demonstrated enhanced growth, activation and hypomethylation of the H-ras gene. These cells also displayed altered morphology. This study indicates that drugs such as ddI may exert their adverse effects through non-genotoxic mechanisms. Such changes in the overall methylation status could result in the activation of proto-oncogenes, such as ras, that are involved in the signal transduction pathway.
Keywords: Animal Cell Line, Transformed Cells, Cultured Didanosine/*PHARMACOLOGY *Genes, ras Methylation Pancreas/CYTOLOGY/*DRUG EFFECTS/METABOLISM Rats S-Adenosylmethionine/*METABOLISM Signal Transduction ABSTRACTKWDanimalcellline,transformedcells,cultureddidanosine/KWDpharmacologyKWDgenes,rasmethylationpancreas/cytology/KWDdrugeffects/metabolismratss-adenosylmethionine/KWDmetabolismsignaltransductionabstract
980228
M9820759

Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .